| Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology LE Rojo, PA Gaspar, H Silva, L Risco, P Arena, K Cubillos-Robles, B Jara Pharmacological research 101, 74-85, 2015 | 228 | 2015 |
| Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications PA Gaspar, ML Bustamante, H Silva, F Aboitiz Journal of neurochemistry 111 (4), 891-900, 2009 | 123 | 2009 |
| The effect of a mindfulness-based intervention in cognitive functions and psychological well-being applied as an early intervention in schizophrenia and high-risk mental state … ÁI Langer, C Schmidt, R Mayol, M Díaz, J Lecaros, E Krogh, A Pardow, ... Trials 18, 1-9, 2017 | 69 | 2017 |
| Cognitive impairment in agricultural workers and nearby residents exposed to pesticides in the Coquimbo Region of Chile SA Corral, V de Angel, N Salas, L Zúńiga-Venegas, PA Gaspar, F Pancetti Neurotoxicology and teratology 62, 13-19, 2017 | 65 | 2017 |
| From molecules to the clinic: linking schizophrenia and metabolic syndrome through sphingolipids metabolism RI Castillo, LE Rojo, M Henriquez-Henriquez, H Silva, A Maturana, ... Frontiers in neuroscience 10, 488, 2016 | 57 | 2016 |
| P300 amplitude is insensitive to working memory load in schizophrenia PA Gaspar, S Ruiz, F Zamorano, M Altayó, C Pérez, CA Bosman, F Aboitiz Bmc Psychiatry 11, 1-6, 2011 | 56 | 2011 |
| BDNF as a biomarker of cognition in schizophrenia/psychosis: an updated review RR Nieto, A Carrasco, S Corral, R Castillo, PA Gaspar, ML Bustamante, ... Frontiers in psychiatry 12, 662407, 2021 | 55 | 2021 |
| Neural oscillatory deficits in schizophrenia predict behavioral and neurocognitive impairments A Martínez, PA Gaspar, SA Hillyard, S Bickel, P Lakatos, EC Dias, ... Frontiers in human neuroscience 9, 371, 2015 | 45 | 2015 |
| Impaired motion processing in schizophrenia and the attenuated psychosis syndrome: etiological and clinical implications A Martínez, PA Gaspar, SA Hillyard, SK Andersen, J Lopez-Calderon, ... American Journal of Psychiatry 175 (12), 1243-1254, 2018 | 41 | 2018 |
| Automatic language analysis identifies and predicts schizophrenia in first-episode of psychosis A Figueroa-Barra, D Del Aguila, M Cerda, PA Gaspar, LD Terissi, ... Schizophrenia 8 (1), 53, 2022 | 23 | 2022 |
| Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS SW Woods, S Parker, MJ Kerr, BC Walsh, SA Wijtenburg, N Prunier, ... Early Intervention in Psychiatry 18 (4), 255-272, 2024 | 18 | 2024 |
| Early psychosis detection program in Chile: a first step for the South American challenge in psychosis research PA Gaspar, RI Castillo, A Maturana, MJ Villar, K Ulloa, G González, ... Early intervention in psychiatry 13 (2), 328-334, 2019 | 16 | 2019 |
| Shifting the focus toward rare variants in schizophrenia to close the gap from genotype to phenotype ML Bustamante, L Herrera, PA Gaspar, R Nieto, A Maturana, MJ Villar, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 174 …, 2017 | 13 | 2017 |
| The aberrant connectivity hypothesis in schizophrenia PA Gaspar, C Bosman, S Ruiz, F Aboitiz From Attention to Goal-Directed Behavior. Neurodynamics of Attentional …, 2009 | 13 | 2009 |
| From glutamatergic dysfunction to cognitive impairment: boundaries in the therapeutic of the schizophrenia P A Gaspar, M L Bustamante, L E Rojo, A Martinez Current pharmaceutical biotechnology 13 (8), 1543-1548, 2012 | 11 | 2012 |
| Examining the effect of a mindfulness based program for the improvement of cognitive function in an early stage of schizophrenia. A random controlled trial ÁI Langer, C Schmidt, R Vergara, R Mayol Troncoso, J Lecaros, E Krogh, ... Elsevier, 2020 | 10 | 2020 |
| Disease-specific contribution of pulvinar dysfunction to impaired emotion recognition in schizophrenia A Martínez, RH Tobe, PA Gaspar, D Malinsky, EC Dias, P Sehatpour, ... Frontiers in Behavioral Neuroscience 15, 787383, 2022 | 9 | 2022 |
| Molecular targets in the rational design of AD specific PET tracers: tau or amyloid aggregates? L E. Rojo, P A. Gaspar, R B. Maccioni Current Alzheimer Research 8 (6), 652-658, 2011 | 8 | 2011 |
| Accelerating medicines partnership® Schizophrenia (AMP® SCZ): Rationale and study design of the largest global prospective cohort study of clinical high risk for psychosis CMJ Wannan, B Nelson, J Addington, K Allott, A Anticevic, C Arango, ... Schizophrenia bulletin 50 (3), 496-512, 2024 | 7 | 2024 |
| Parametric increases of working memory load unveil a decreased alpha oscillatory activity in schizophrenia PA Gaspar, CA Bosman, S Ruiz, F Zamorano, C Pérez, F Aboitiz | 7 | 2011 |
Daniel JavittDepartments of Psychiatry and Neuroscience, Nathan Kline Institute & Columbia UniversityVerified email at columbia.edu
